Last reviewed · How we verify

long term tapering of prednisolone

Institute of Child Health · FDA-approved active Small molecule Quality 5/100

long term tapering of prednisolone is a Small molecule drug developed by Institute of Child Health. It is currently FDA-approved.

At a glance

Generic namelong term tapering of prednisolone
SponsorInstitute of Child Health
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about long term tapering of prednisolone

What is long term tapering of prednisolone?

long term tapering of prednisolone is a Small molecule drug developed by Institute of Child Health.

Who makes long term tapering of prednisolone?

long term tapering of prednisolone is developed and marketed by Institute of Child Health (see full Institute of Child Health pipeline at /company/institute-of-child-health).

What development phase is long term tapering of prednisolone in?

long term tapering of prednisolone is FDA-approved (marketed).

Related